1 completed, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Healthy Control: new trials by email Literature Review of Healthy Control trials Research Report on Healthy Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OMAR Opioid Use Disorder [11C]OMAR - Healthy Control, Opioid Use Disorder | Phase 1 | Recruiting | Yale University | 30 | 2023-03-10 | 2026-09-10 |
| Metabolism of Bioactive Dietary Polyphenol Preparation (BDPP) Trans-resveratrol, Concord grape juice, Grape seed polyphenol extract - Healthy Control | Phase 1 | Completed | Icahn School of Medicine at Mount Sinai | 84 | 2021-01-19 | 2025-03-03 |
Chemically-Induced Disorders (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Substance-Related Disorders (1)
4-cyano-1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (1) · Resveratrol (1)
Icahn School of Medicine at Mount Sinai (1) · Yale University (1)
United States (2)
Anahita Bassir Nia, MD (1) · James Murrough, MD, PhD (1)
K12DA000167 (1), R21DA052864 (1), U19AT010835 (1)